0001628280-23-024232.txt : 20230705
0001628280-23-024232.hdr.sgml : 20230705
20230705160712
ACCESSION NUMBER: 0001628280-23-024232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Persson Magnus
CENTRAL INDEX KEY: 0001653222
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 231068839
MAIL ADDRESS:
STREET 1: 400 E. PRATT STREET
STREET 2: SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wk-form4_1688587616.xml
FORM 4
X0407
4
2023-06-30
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001653222
Persson Magnus
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
0
Stock Option (Right to Buy)
0.3552
2023-06-30
4
A
0
28308
0
A
2023-06-30
2033-06-30
Common Stock
28308
28308
D
100% of the stock option will immediately vest on the date that it is granted.
/s/ Christopher Sullivan, by Power of Attorney
2023-07-05